These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34603023)

  • 121. Lonicera japonica Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Mice: Molecular Mechanisms of Action.
    Miao H; Zhang Y; Huang Z; Lu B; Ji L
    Am J Chin Med; 2019; 47(2):351-367. PubMed ID: 30871359
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Immunomodulatory activity of a novel polysaccharide from Lonicera japonica in immunosuppressed mice induced by cyclophosphamide.
    Zhou X; Dong Q; Kan X; Peng L; Xu X; Fang Y; Yang J
    PLoS One; 2018; 13(10):e0204152. PubMed ID: 30296293
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Neochlorogenic acid inhibits against LPS-activated inflammatory responses through up-regulation of Nrf2/HO-1 and involving AMPK pathway.
    Park SY; Jin ML; Yi EH; Kim Y; Park G
    Environ Toxicol Pharmacol; 2018 Sep; 62():1-10. PubMed ID: 29908432
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis.
    Panahi Y; Hosseini MS; Khalili N; Naimi E; Majeed M; Sahebkar A
    Clin Nutr; 2015 Dec; 34(6):1101-8. PubMed ID: 25618800
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
    Moher D; Liberati A; Tetzlaff J; Altman DG;
    BMJ; 2009 Jul; 339():b2535. PubMed ID: 19622551
    [No Abstract]   [Full Text] [Related]  

  • 126. Add-On Effect of Honeysuckle in the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    Du XQ; Shi LP; Cao WF; Chen ZW; Zuo B; Hu JY
    Front Pharmacol; 2021; 12():708636. PubMed ID: 34603023
    [No Abstract]   [Full Text] [Related]  

  • 127. A systematic review of outcomes in COVID-19 patients treated with western medicine in combination with traditional Chinese medicine versus western medicine alone.
    Yu R; Zhang S; Zhao D; Yuan Z
    Expert Rev Mol Med; 2022 Jan; 24():e5. PubMed ID: 34986905
    [TBL] [Abstract][Full Text] [Related]  

  • 128. [Systematic review and meta-analysis of randomized controlled trials of integrative medicine therapy for treatment of chronic severe hepatitis].
    Liu HM; Wang XB; Chang YJ; Gu LL
    Zhong Xi Yi Jie He Xue Bao; 2012 Nov; 10(11):1211-28. PubMed ID: 23158939
    [TBL] [Abstract][Full Text] [Related]  

  • 129. [Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in the treatment of Sjogren's syndrome].
    Luo H; Han M; Liu JP
    Zhong Xi Yi Jie He Xue Bao; 2011 Mar; 9(3):257-74. PubMed ID: 21419078
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Efficacy and safety of Xuebijing injection (a Chinese patent) for sepsis: A meta-analysis of randomized controlled trials.
    Li C; Wang P; Zhang L; Li M; Lei X; Liu S; Feng Z; Yao Y; Chang B; Liu B; Shang H
    J Ethnopharmacol; 2018 Oct; 224():512-521. PubMed ID: 29860133
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Ang L; Song E; Lee HW; Lee MS
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32456123
    [TBL] [Abstract][Full Text] [Related]  

  • 132. [Chinese herbal medicine for side effects of transarterial chemoembolization in liver cancer patients: a systematic review and meta-analysis].
    Li XQ; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2012 Dec; 10(12):1341-62. PubMed ID: 23257126
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Contribution of Chinese herbal medicine in the treatment of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis of randomized controlled trials.
    Jin D; Wang J; Xue J; Zhao Y; Yan G; Li X; Wang X
    Phytother Res; 2023 Mar; 37(3):1015-1035. PubMed ID: 36382689
    [TBL] [Abstract][Full Text] [Related]  

  • 134. A Chinese patent medicine Salvia miltiorrhiza depside salts for infusion combined with conventional treatment for patients with angina pectoris: A systematic review and meta-analysis of randomized controlled trials.
    Zhang Y; Xie Y; Liao X; Jia Q; Chai Y
    Phytomedicine; 2017 Feb; 25():100-117. PubMed ID: 28190464
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Chinese herbal medicine for primary dysmenorrhoea.
    Zhu X; Proctor M; Bensoussan A; Wu E; Smith CA
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005288. PubMed ID: 18425916
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Evidence Mapping of 23 Systematic Reviews of Traditional Chinese Medicine Combined With Western Medicine Approaches for COVID-19.
    Zhang T; Li X; Chen Y; Zhao L; Tian J; Zhang J
    Front Pharmacol; 2021; 12():807491. PubMed ID: 35197851
    [No Abstract]   [Full Text] [Related]  

  • 137. Comparison of effectiveness and safety between granules and decoction of Chinese herbal medicine: a systematic review of randomized clinical trials.
    Luo H; Li Q; Flower A; Lewith G; Liu J
    J Ethnopharmacol; 2012 Apr; 140(3):555-67. PubMed ID: 22343092
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Oral traditional Chinese medication for adhesive small bowel obstruction.
    Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
    Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
    [TBL] [Abstract][Full Text] [Related]  

  • 139. The efficacy and safety of Chinese herbal medicine, Rhodiola formulation in treating ischemic heart disease: a systematic review and meta-analysis of randomized controlled trials.
    Yu L; Qin Y; Wang Q; Zhang L; Liu Y; Wang T; Huang L; Wu L; Xiong H
    Complement Ther Med; 2014 Aug; 22(4):814-25. PubMed ID: 25146085
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Traditional Chinese medicinal herbs combined with epidermal growth factor receptor tyrosine kinase inhibitor for advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Liu ZL; Zhu WR; Zhou WC; Ying HF; Zheng L; Guo YB; Chen JX; Shen XH
    J Integr Med; 2014 Jul; 12(4):346-58. PubMed ID: 25074884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.